SCHEMBL837719

SCHEMBL837719

c1ccc([PH](CCCCCCCCCC[PH](c2ccccc2)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 2/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
GLA P06280 1/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA9 Q16790 1/20 0.32
CA14 Q9ULX7 1/20 0.32
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
POLB P06746 1/20 0.31
BLM P54132 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
MAPT P10636 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
LMNA P02545 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL837455 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL6767743 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL837999 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL12787153 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL12787155 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL837701 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL837395 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL11897049 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL12787151 1.00 TSHR (0.38) TSHRTDP1CA12CA1CA2
SCHEMBL838143 0.97 TSHR (0.39) TSHRTDP1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200166839-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR, RESIN COMPOSITION FOR PRODUCING LITHOGRAPHIC PRINTING PLATE PRECURSOR, AND METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2020-05-28 US disclosed
US-9801922-B2 Compositions and methods of treating cancer UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2017-10-31 US disclosed
US-9801922-B2 Compositions and methods of treating cancer UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2017-10-31 US disclosed
US-9801922-B2 Compositions and methods of treating cancer UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2017-10-31 US disclosed
US-20140228290-A1 COMPOSITIONS AND METHODS OF TREATING CANCER REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-08-14 US disclosed
US-20140228290-A1 COMPOSITIONS AND METHODS OF TREATING CANCER REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-08-14 US disclosed
US-20140228290-A1 COMPOSITIONS AND METHODS OF TREATING CANCER REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2014-08-14 US disclosed
US-8714088-B2 Lithographic printing plate precursor and lithographic printing method FUJIFILM CORPORATION (JP) 2014-05-06 US disclosed
US-8399172-B2 Negative-working lithographic printing plate precursor and method of lithographic printing using same FUJIFILM CORPORATION (JP) 2013-03-19 US disclosed
WO-2013019975-A1 COMPOSITIONS AND METHODS OF TREATING CANCER UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2013-02-07 WO disclosed
US-20090047601-A1 PLANOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-02-19 US disclosed
US-20080286685-A1 PLANOGRAPHIC PRINTING PLATE PRECURSOR AND PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-11-20 US disclosed
US-20080254384-A1 Cyanine dye containing methine chain and onium salt structure FUJIFILM CORPORATION (JP) 2008-10-16 US disclosed
US-20080233516-A1 NEGATIVE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2008-09-25 US disclosed
US-20080096132-A1 mixing a polymerizable monomer in which acrylonitrile accounts for 70% by weight or more of a total of the polymerizable monomer, water and an alkali metal persulfate polymerization initiator to conduct emulsion polymerization; distilling off unpolymerized monomers; chemical resistance film, gas barrier FUJIFILM CORPORATION 2008-04-24 US disclosed
US-20080087183-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORPORATION (JP) 2008-04-17 US disclosed
US-20070214987-A1 Lithographic printing plate precursor FUJIFILM CORPORATION 2007-09-20 US disclosed
US-20070042293-A1 Including an aromatic diphosphonium compound along with an addition polymerization promoter, unsaturated compound, protective layeron an sluminium support; laser recording having excellent ink receptibility during printing and printing durability; strength; on-press development; image strength FUJI PHOTO FILM CO., LTD. 2007-02-22 US disclosed
EP-0578794-A1 METHOD OF IMPROVING THE HEAT-INSULATION PROPERTIES OF POLYAMIDE 6.6 FILAMENTS, AND FILAMENTS PRODUCED BY THIS METHOD Rhône-Poulenc Viscosuisse SA (CH) 1994-01-19 EP disclosed
WO-1993015138-A1 METHOD OF IMPROVING THE HEAT-INSULATION PROPERTIES OF POLYAMIDE 6.6 FILAMENTS, AND FILAMENTS PRODUCED BY THIS METHOD RHONE-POULENC VISCOSUISSE S.A. (CH) 1993-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080254384-A1 Cyanine dye containing methine chain and onium salt structure INMT, MGMT, IK TSHR 3985/4885TDP1 1081/4885CA12 243/4885
US-20140228290-A1 COMPOSITIONS AND METHODS OF TREATING CANCER TXN2, TXNRD2, PRDX5 TSHR 4081/4885TDP1 1228/4885CA12 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.